Pomanda estimates the enterprise value of SAFC BIOSCIENCES LIMITED at £15.1m based on a Turnover of £31.7m and 0.48x industry multiple (adjusted for size and gross margin).
safc biosciences limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of SAFC BIOSCIENCES LIMITED at £0 based on an EBITDA of £-1m and a 3.14x industry multiple (adjusted for size and gross margin).
safc biosciences limitedEstimated Valuation
£17m
Pomanda estimates the enterprise value of SAFC BIOSCIENCES LIMITED at £17m based on Net Assets of £8.8m and 1.93x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Safc Biosciences LimitedOverview
Safc Biosciences Limited is a live company located in gillingham, SP8 4XT with a Companies House number of 03195318. It operates in the manufacture of other chemical products n.e.c. sector, SIC Code 20590. Founded in May 1996, it's largest shareholder is
sigma-aldrich company ltd
with a 100% stake. Safc Biosciences Limited is a mature,
large sized company, Pomanda has estimated its turnover at
£31.7m with
low
growth in recent years.
Pomanda's financial health check has awarded Safc Biosciences Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
3 Strong
2 Regular
4 Weak
Size
annual sales of £31.7m, make it larger than the average company (£21m)
£31.7m - Safc Biosciences Limited
£21m - Industry AVG
Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (8.1%)
1% - Safc Biosciences Limited
8.1% - Industry AVG
Production
with a gross margin of -2.9%, this company has a higher cost of product (29.5%)
-2.9% - Safc Biosciences Limited
29.5% - Industry AVG
Profitability
an operating margin of -3.3% make it less profitable than the average company (5.9%)
-3.3% - Safc Biosciences Limited
5.9% - Industry AVG
Employees
with 89 employees, this is above the industry average (55)
89 - Safc Biosciences Limited
55 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Safc Biosciences Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £355.7k, this is equally as efficient (£358.8k)
£355.7k - Safc Biosciences Limited
£358.8k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Safc Biosciences Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 6 days, this is quicker than average (37 days)
6 days - Safc Biosciences Limited
37 days - Industry AVG
Stock Days
it holds stock equivalent to 78 days, this is in line with average (66 days)
78 days - Safc Biosciences Limited
66 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Safc Biosciences Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7.9%, this is a lower level of debt than the average (40%)
7.9% - Safc Biosciences Limited
40% - Industry AVG
SAFC BIOSCIENCES LIMITED financials
EXPORT
Safc Biosciences Limited's latest turnover from December 2023 is £31.7 million and the company has net assets of £8.8 million. According to their latest financial statements, we estimate that Safc Biosciences Limited has 89 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
31,656,000
33,531,000
28,682,000
30,804,000
33,963,000
43,654,000
38,561,000
41,198,000
34,333,000
29,905,000
31,557,000
25,848,000
32,165,000
27,894,000
29,044,000
Other Income Or Grants
Cost Of Sales
32,577,000
32,379,000
28,624,000
28,755,000
31,946,000
40,674,000
36,955,000
38,231,000
31,926,000
27,268,000
29,775,000
24,223,000
29,319,000
25,030,000
25,886,000
Gross Profit
-921,000
1,152,000
58,000
2,049,000
2,017,000
2,980,000
1,606,000
2,967,000
2,407,000
2,637,000
1,782,000
1,625,000
2,846,000
2,864,000
3,158,000
Admin Expenses
110,000
125,000
127,000
84,000
32,000
14,000
22,000
18,000
19,000
18,000
24,000
88,000
621,000
1,140,000
1,217,000
Operating Profit
-1,031,000
1,027,000
-69,000
1,965,000
1,985,000
2,966,000
1,584,000
2,949,000
2,388,000
2,619,000
1,758,000
1,537,000
2,225,000
1,724,000
1,941,000
Interest Payable
1,000
8,000
9,000
19,000
14,000
Interest Receivable
99,000
49,000
6,000
134,000
92,000
22,000
85,000
94,000
88,000
115,000
48,000
37,000
63,000
Pre-Tax Profit
-933,000
1,076,000
-77,000
1,971,000
2,214,000
3,039,000
1,592,000
2,949,000
2,473,000
2,713,000
1,846,000
1,652,000
2,273,000
1,761,000
2,004,000
Tax
219,000
-204,000
15,000
-375,000
-402,000
-578,000
-306,000
-591,000
-501,000
-591,000
-425,000
-397,000
-776,000
-540,000
-529,000
Profit After Tax
-714,000
872,000
-62,000
1,596,000
1,812,000
2,461,000
1,286,000
2,358,000
1,972,000
2,122,000
1,421,000
1,255,000
1,497,000
1,221,000
1,475,000
Dividends Paid
20,458,000
1,577,000
749,000
2,250,000
Retained Profit
-714,000
872,000
-62,000
1,596,000
-18,646,000
2,461,000
-291,000
2,358,000
1,972,000
2,122,000
1,421,000
1,255,000
1,497,000
472,000
-775,000
Employee Costs
456,000
891,000
827,000
Number Of Employees
89
101
98
118
123
151
141
169
134
114
118
102
15
24
24
EBITDA*
-1,031,000
1,027,000
-69,000
1,965,000
1,985,000
2,966,000
1,584,000
2,949,000
2,388,000
2,619,000
1,758,000
1,537,000
2,581,000
2,304,000
2,315,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
356,000
936,000
Intangible Assets
Investments & Other
548,000
548,000
548,000
Debtors (Due After 1 year)
Total Fixed Assets
548,000
548,000
548,000
356,000
936,000
Stock & work in progress
7,033,000
5,937,000
3,664,000
2,505,000
3,600,000
3,060,000
3,513,000
2,855,000
3,225,000
3,298,000
3,512,000
2,023,000
3,079,000
3,921,000
2,162,000
Trade Debtors
489,000
352,000
Group Debtors
1,662,000
2,430,000
4,571,000
5,406,000
4,434,000
20,576,000
19,948,000
21,461,000
18,543,000
5,635,000
3,999,000
3,158,000
1,641,000
4,044,000
2,544,000
Misc Debtors
873,000
1,661,000
1,042,000
723,000
263,000
2,857,000
248,000
8,000
125,000
71,000
232,000
104,000
408,000
163,000
227,000
Cash
70,000
13,505,000
12,305,000
12,130,000
10,561,000
6,960,000
8,582,000
misc current assets
total current assets
9,568,000
10,028,000
9,277,000
9,123,000
8,649,000
26,493,000
23,709,000
24,324,000
21,963,000
22,509,000
20,048,000
17,415,000
15,689,000
15,088,000
13,515,000
total assets
9,568,000
10,028,000
9,277,000
9,123,000
8,649,000
27,041,000
24,257,000
24,872,000
21,963,000
22,509,000
20,048,000
17,415,000
15,689,000
15,444,000
14,451,000
Bank overdraft
Bank loan
Trade Creditors
617,000
320,000
247,000
167,000
483,000
399,000
375,000
363,000
355,000
273,000
226,000
242,000
76,000
201,000
167,000
Group/Directors Accounts
848,000
2,607,000
2,606,000
2,606,000
2,058,000
4,624,000
4,081,000
3,267,000
2,643,000
3,680,000
3,016,000
other short term finances
hp & lease commitments
other current liabilities
136,000
179,000
373,000
237,000
195,000
324,000
26,000
362,000
367,000
401,000
652,000
238,000
518,000
309,000
440,000
total current liabilities
753,000
499,000
620,000
404,000
1,526,000
3,330,000
3,007,000
3,331,000
2,780,000
5,298,000
4,959,000
3,747,000
3,237,000
4,190,000
3,623,000
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
39,000
338,000
384,000
total long term liabilities
39,000
338,000
384,000
total liabilities
753,000
499,000
620,000
404,000
1,526,000
3,330,000
3,007,000
3,331,000
2,780,000
5,298,000
4,959,000
3,747,000
3,276,000
4,528,000
4,007,000
net assets
8,815,000
9,529,000
8,657,000
8,719,000
7,123,000
23,711,000
21,250,000
21,541,000
19,183,000
17,211,000
15,089,000
13,668,000
12,413,000
10,916,000
10,444,000
total shareholders funds
8,815,000
9,529,000
8,657,000
8,719,000
7,123,000
23,711,000
21,250,000
21,541,000
19,183,000
17,211,000
15,089,000
13,668,000
12,413,000
10,916,000
10,444,000
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
-1,031,000
1,027,000
-69,000
1,965,000
1,985,000
2,966,000
1,584,000
2,949,000
2,388,000
2,619,000
1,758,000
1,537,000
2,225,000
1,724,000
1,941,000
Depreciation
356,000
580,000
374,000
Amortisation
Tax
219,000
-204,000
15,000
-375,000
-402,000
-578,000
-306,000
-591,000
-501,000
-591,000
-425,000
-397,000
-776,000
-540,000
-529,000
Stock
1,096,000
2,273,000
1,159,000
-1,095,000
540,000
-453,000
658,000
-370,000
-73,000
-214,000
1,489,000
-1,056,000
-842,000
1,759,000
2,162,000
Debtors
-1,556,000
-1,522,000
-1,005,000
1,569,000
-18,384,000
3,237,000
-1,273,000
2,801,000
12,962,000
1,475,000
969,000
1,213,000
-2,158,000
1,436,000
2,771,000
Creditors
297,000
73,000
80,000
-316,000
84,000
24,000
12,000
8,000
82,000
47,000
-16,000
166,000
-125,000
34,000
167,000
Accruals and Deferred Income
-43,000
-194,000
136,000
42,000
-129,000
298,000
-336,000
-5,000
-34,000
-251,000
414,000
-280,000
209,000
-131,000
440,000
Deferred Taxes & Provisions
-39,000
-299,000
-46,000
384,000
Cash flow from operations
-98,000
-49,000
8,000
842,000
19,382,000
-74,000
1,569,000
-70,000
-10,954,000
563,000
-727,000
830,000
4,590,000
-1,574,000
-2,156,000
Investing Activities
capital expenditure
-1,310,000
Change in Investments
-548,000
548,000
cash flow from investments
548,000
-548,000
-1,310,000
Financing Activities
Bank loans
Group/Directors Accounts
-848,000
-1,759,000
1,000
548,000
-2,566,000
543,000
814,000
624,000
-1,037,000
664,000
3,016,000
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
2,058,000
11,219,000
interest
98,000
49,000
-8,000
6,000
125,000
73,000
8,000
85,000
94,000
88,000
115,000
48,000
37,000
63,000
cash flow from financing
98,000
49,000
-8,000
-842,000
424,000
74,000
8,000
548,000
-2,481,000
637,000
902,000
739,000
-989,000
701,000
14,298,000
cash and cash equivalents
cash
-70,000
-13,435,000
1,200,000
175,000
1,569,000
3,601,000
-1,622,000
8,582,000
overdraft
change in cash
-70,000
-13,435,000
1,200,000
175,000
1,569,000
3,601,000
-1,622,000
8,582,000
safc biosciences limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for safc biosciences limited. Get real-time insights into safc biosciences limited's credit score, group structure and payment trends.
Perform a competitor analysis for safc biosciences limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in SP8 area or any other competitors across 12 key performance metrics.
safc biosciences limited Ownership
SAFC BIOSCIENCES LIMITED group structure
Safc Biosciences Limited has no subsidiary companies.
20590 - Manufacture of other chemical products n.e.c.
incorporation date
May 1996
age
29
incorporated
UK
ultimate parent company
MERCK KGAA
accounts
Full Accounts
last accounts submitted
December 2023
previous names
jrh biosciences limited (January 2006)
jrh europe limited (October 1999)
accountant
-
auditor
DELOITTE LLP
address
the old brickyard, new road, gillingham, dorset, SP8 4XT
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
safc biosciences limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to safc biosciences limited.
safc biosciences limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SAFC BIOSCIENCES LIMITED. This can take several minutes, an email will notify you when this has completed.
safc biosciences limitedCompanies House Filings - See Documents
